English
Home > Products > CAS:595-33-5

China CAS:595-33-5 Manufacturer

Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for CAS:595-33-5, Our firm quickly grew in size and reputation because of its absolute dedication to superior quality manufacturing, substantial price of solutions and fantastic customer services.
CAS:595-33-5, Our company insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thank all old and new customers' support. We'll keep working hard and offering you the highest-quality goods and service.

Related Products

Hot Products

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Dienogest

    Dienogest

    Dienogest has EP specifications. DMF approved.

    CAS:65928-58-7

  • 17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate is an endogenous progesteroid hormone similar to progesterone.

    CAS:302-23-8

  • Oxcarbazepine

    Oxcarbazepine

    Oxcarbazepine has CP, EP and USP specifications. CEP and DMF available, GMP approved.

    CAS:28721-07-5

  • Mifepristone Tablets

    Mifepristone Tablets

    Mifepristone Tablets Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Related Blog
  • Reviews

  • 2019 CPhI China Exhibition Shanghai

    June 2019
    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • Gedian Humanwell successfully passed the EDQM audit

    The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

  • Join Us at Booth N25 for CPHI Korea 2025 in Seoul

  • What Is Epiandrosterone and Why Is It Becoming Popular in Modern Hormone Research

    In recent years, Epiandrosterone has gained increasing attention in biochemical research, pharmaceutical development, and hormone metabolism studies. As a naturally occurring androgen metabolite, this compound plays an important role in steroid biosynthesis and endocrine pathways. Scientists and manufacturers are exploring its potential applications in hormone research, biochemical analysis, and advanced pharmaceutical intermediates.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept